The Massachusetts Legislature held a meeting on June 23, 2025, to discuss the public health effects of xylazine, a substance increasingly found in illicit drugs. A significant focus of the meeting was the distribution of xylazine and fentanyl test strips at three sites, which provide users a way to check for contaminants in their drugs. However, officials noted that while these test strips are helpful, they are not foolproof.

During the meeting, Dr. Green was invited to elaborate on the effectiveness and limitations of these testing methods after her presentation. The discussion highlighted the importance of harm reduction strategies in addressing the growing concerns surrounding drug contamination and its health implications.

Senator Vilas expressed gratitude for the informative session and sought clarification on key points made during the meeting, underscoring the need for continued dialogue on this pressing public health issue.

The meeting concluded with a commitment to further explore effective strategies for mitigating the risks associated with xylazine and other harmful substances in the community. The ongoing discussions aim to enhance public awareness and safety as the state navigates the challenges posed by drug-related health crises.